These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1563)

  • 1. The clinical use of dopamine in the treatment of shock.
    Reid PR; Thompson WL
    Johns Hopkins Med J; 1975 Dec; 137(6):276-9. PubMed ID: 1563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of catecholamines in acute myocardial infarction.
    Dixon DW; Loeb HS; Gunnar RM
    Herz; 1979 Oct; 4(5):385-96. PubMed ID: 391685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of dopamine in the treatment of shock states].
    Wattel F; Chopin C; Gosselin B; Durocher A; Vallet D; Stevigny R; Ramon P; Berzin B
    Anesth Analg (Paris); 1976; 33(3):355-74. PubMed ID: 1015658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
    Olsen NV
    Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic support in cardiogenic shock.
    Rude RE
    Adv Shock Res; 1983; 10():35-49. PubMed ID: 6349299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine versus norepinephrine: is one better?
    Vincent JL; Biston P; Devriendt J; Brasseur A; De Backer D
    Minerva Anestesiol; 2009 May; 75(5):333-7. PubMed ID: 19412154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressors and low-flow states.
    Hershey SG; Altura BM
    Clin Anesth; 1974; 10(1):31-76. PubMed ID: 4149702
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacologic basis and application of catecholamines in the treatment of shock].
    Wang TG; Wang CW; Tseng YM
    Zhonghua Yi Xue Za Zhi; 1974; 3():183-8. PubMed ID: 4151131
    [No Abstract]   [Full Text] [Related]  

  • 10. Adrenergic agonists and antagonists in the treatment of hypovolemic shock.
    Williamson M
    J Am Med Womens Assoc; 1969 Dec; 24(12):951-6 passim. PubMed ID: 4391032
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock.
    Zhou SX; Qiu HB; Huang YZ; Yang Y; Zheng RQ
    Acta Pharmacol Sin; 2002 Jul; 23(7):654-8. PubMed ID: 12100762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Catecholamine therapy in cardiogenic shock: helpful, useless or dangerous?].
    Schwertz H; Müller-Werdan U; Prondzinsky R; Werdan K; Buerke M
    Dtsch Med Wochenschr; 2004 Sep; 129(37):1925-30. PubMed ID: 15372372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of dopamin in shock and heart failure (author's transl)].
    Aroński A; Kübler A; Sliwinski M; Paszkowska A
    Anaesthesist; 1978 Apr; 27(4):183-6. PubMed ID: 655365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dopamine in patients with cardiogenic shock (author's transl)].
    Kikis D; Esser H; Trübestein G
    Med Klin; 1977 Jul; 72(28-29):1212-7. PubMed ID: 329088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenergic drug therapy in newborn canine endotoxic shock.
    Goto M; Griffin AJ; Chiemmongkoltip P; Ohya N
    Circ Shock; 1990 Oct; 32(2):123-32. PubMed ID: 1979257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine--clinical uses of an endogenous catecholamine.
    Goldberg LI
    N Engl J Med; 1974 Oct; 291(14):707-10. PubMed ID: 4604342
    [No Abstract]   [Full Text] [Related]  

  • 17. The use and misuse of pressor agents.
    Smith NT; Corbascio AN
    Anesthesiology; 1970 Jul; 33(1):58-101. PubMed ID: 4393417
    [No Abstract]   [Full Text] [Related]  

  • 18. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
    El Mokhtari NE; Arlt A; Meissner A; Lins M
    Eur J Med Res; 2007 Nov; 12(11):563-7. PubMed ID: 18024265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacotherapy of cardiogenic shock].
    Ritz R
    Schweiz Med Wochenschr; 1988 Apr; 118(17):626-9. PubMed ID: 2898169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular mechanisms of thyrotropin-releasing hormone against experimental hemorrhagic shock.
    Zheng D; Chen HS; Hu DY
    Circ Shock; 1992 Mar; 36(3):169-73. PubMed ID: 1611701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.